Vektor Medical Inc.

Vektor Medical develops vMap, an FDA-cleared and CE-marked arrhythmia analysis software platform that uses artificial intelligence to extract diagnostic insights from standard 12-lead ECGs. vMap provides non-invasive, four-chamber cardiac mapping and analysis for seven arrhythmia types, including atrial fibrillation, atrial and ventricular tachycardia, ventricular fibrillation, pacing, premature atrial and ventricular complexes (PACs and PVCs), and orthodromic atrioventricular reentrant tachycardia. The software is designed to integrate into current cardiac ablation workflows, improving procedural outcomes and efficiency for electrophysiologists and cardiac care teams. vMap addresses a significant clinical need in arrhythmia management; arrhythmias account for approximately 10% of global deaths, and over 25% of adults over age 40 develop serious arrhythmias. The company is based in San Diego and was recognized as UC San Diego Chancellor's Innovation Awards Startup of the Year in 2024. Regulatory status: FDA 510(k) clearance and CE mark.